Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference
Krystal Biotech (NASDAQ: KRYS), a commercial-stage biotechnology company, has announced its participation in the 2024 Cantor Global Healthcare Conference on September 18, 2024, in New York. Krish S. Krishnan, Chairman and CEO, will engage in a fireside chat at 1:20 pm ET and conduct investor meetings throughout the day.
A webcast of the presentation will be available starting at 1:20 pm ET on Wednesday, September 18, 2024, and will be accessible on the Investors section of the company's website. This event provides an opportunity for Krystal Biotech to showcase its developments and engage with investors in the healthcare sector.
Krystal Biotech (NASDAQ: KRYS), un'azienda biofarmaceutica in fase commerciale, ha annunciato la sua partecipazione alla Conferenza Sanitaria Globale Cantor 2024 il 18 settembre 2024 a New York. Krish S. Krishnan, Presidente e CEO, parteciperà a un colloquio informale alle 13:20 ET e condurrà incontri con investitori durante tutta la giornata.
Un webcast della presentazione sarà disponibile a partire dalle 13:20 ET di mercoledì 18 settembre 2024 e sarà accessibile nella sezione Investitori del sito web dell'azienda. Questo evento offre un'opportunità per Krystal Biotech di mostrare i suoi sviluppi e interagire con gli investitori nel settore sanitario.
Krystal Biotech (NASDAQ: KRYS), una empresa de biotecnología en etapa comercial, ha anunciado su participación en la Conferencia Global de Salud Cantor 2024 el 18 de septiembre de 2024 en Nueva York. Krish S. Krishnan, Presidente y CEO, participará en una charla informal a la 1:20 pm ET y llevará a cabo reuniones con inversores durante todo el día.
Una transmisión en vivo de la presentación estará disponible a partir de la 1:20 pm ET del miércoles 18 de septiembre de 2024, y será accesible en la sección de Inversores del sitio web de la empresa. Este evento brinda una oportunidad para que Krystal Biotech muestre sus desarrollos e interactúe con inversores del sector de la salud.
Krystal Biotech (NASDAQ: KRYS), 상업 단계의 생명공학 회사가 2024년 9월 18일 뉴욕에서 열리는 2024 Cantor Global Healthcare Conference에 참여한다고 발표했습니다. Krish S. Krishnan 회장 겸 CEO가 오후 1시 20분 ET에 화로 대화에 참여하고 하루 종일 투자자 회의를 진행할 예정입니다.
발표의 웹캐스트는 2024년 9월 18일 수요일 오후 1시 20분 ET부터 이용 가능하며, 회사 웹사이트의 투자자 섹션에서 접속할 수 있습니다. 이 행사는 Krystal Biotech이 자신의 발전을 선보이고 건강 관리 분야의 투자자들과 소통할 수 있는 기회를 제공합니다.
Krystal Biotech (NASDAQ: KRYS), une entreprise de biotechnologie en phase commerciale, a annoncé sa participation à la Conférence Mondiale de la Santé Cantor 2024 le 18 septembre 2024 à New York. Krish S. Krishnan, Président et CEO, participera à une discussion informelle à 13h20 ET et effectuera des réunions avec des investisseurs tout au long de la journée.
Un webinaire de la présentation sera disponible à partir de 13h20 ET le mercredi 18 septembre 2024 et sera accessible dans la section Investisseurs du site Web de l'entreprise. Cet événement offre à Krystal Biotech l'occasion de présenter ses développements et d'interagir avec les investisseurs du secteur de la santé.
Krystal Biotech (NASDAQ: KRYS), ein biotechnologisches Unternehmen in der Handelsphase, hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference am 18. September 2024 in New York bekannt gegeben. Krish S. Krishnan, Vorsitzender und CEO, wird um 13:20 Uhr ET an einem informellen Gespräch teilnehmen und den ganzen Tag über Investorenmeetings abhalten.
Ein Webcast der Präsentation wird ab 13:20 Uhr ET am Mittwoch, den 18. September 2024, verfügbar sein und kann im Bereich Investoren auf der Website des Unternehmens abgerufen werden. Diese Veranstaltung bietet Krystal Biotech die Möglichkeit, ihre Entwicklungen zu präsentieren und mit Investoren im Gesundheitssektor in Kontakt zu treten.
- None.
- None.
PITTSBURGH, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the 2024 Cantor Global Healthcare Conference on September 18, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:20 pm ET and host investor meetings throughout the day.
A webcast of the presentation will be available here beginning at 1:20 pm ET on Wednesday, September 18, 2024 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).
CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com
FAQ
When is Krystal Biotech (KRYS) presenting at the 2024 Cantor Global Healthcare Conference?
Who will represent Krystal Biotech (KRYS) at the 2024 Cantor Global Healthcare Conference?
Where can investors watch the Krystal Biotech (KRYS) presentation from the 2024 Cantor Global Healthcare Conference?
What type of events will Krystal Biotech (KRYS) participate in at the 2024 Cantor Global Healthcare Conference?
